This course has expired. View available courses.
Oncology
Advances in the management of head and neck cancers – the new era of immunotherapies – Certificate of Completion
According to Cancer Australia, there were almost 5000 new cases of head and neck cancer diagnosed in Australia in 2017 making it the seventh most commonly diagnosed cancer in the country. More than 1000 Australians died from head and neck cancers during 2017, with a 5-year relative survival rate of 69% from 2009–2013. This has improved only marginally from 61% in 1984–1988.
SCCHN comprises a heterogeneous group of tumours that arise from the squamous epithelium of the oral cavity, oropharynx, larynx and hypopharynx. While many SCCHNs are related to behavioural risk factors such as smoking and alcohol use, infection with HPV (predominantly HPV-16 subtype) is associated with a clinically, genomically and immunologically distinct subgroup of tumours arising from the epithelium of the tonsil and base of the tongue. HPV-positive SCCHN is becoming increasingly common in many Western countries and is associated with improved prognosis compared with HPV-negative SCCHN.
DURATION
1.5 hrs
PROFESSION
Specialist
# OF CREDITS
1.5
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2020-08-14
According to Cancer Australia, there were almost 5000 new cases of head and neck cancer diagnosed in Australia in 2017 making it the seventh most commonly diagnosed cancer in the country. More than 1000 Australians died from head and neck cancers during 2017, with a 5-year relative survival rate of 69% from 2009–2013. This has improved only marginally from 61% in 1984–1988.
SCCHN comprises a heterogeneous group of tumours that arise from the squamous epithelium of the oral cavity, oropharynx, larynx and hypopharynx. While many SCCHNs are related to behavioural risk factors such as smoking and alcohol use, infection with HPV (predominantly HPV-16 subtype) is associated with a clinically, genomically and immunologically distinct subgroup of tumours arising from the epithelium of the tonsil and base of the tongue. HPV-positive SCCHN is becoming increasingly common in many Western countries and is associated with improved prognosis compared with HPV-negative SCCHN.
Faculty
Associate Professor Alex Guminski
MBBS FRACP PhD
Medical Oncologist, Melanoma Institute Australia, Sydney
North Shore Private Hospital,
Royal North Shore Hospital, Sydney, NSW
Associate Professor Brett Hughes
BSc(Med) MBBS(Hons) FRACP
Senior Staff Specialist Medical Oncologist
Royal Brisbane and Women’s Hospital and
The Prince Charles Hospital Brisbane, QLD
Accreditation
# of credits: 1.5 
Duration: 1.5 hrs FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
